Shenzhen New Industries Biomedical - Asset Resilience Ratio

Latest as of September 2025: 9.95%

Shenzhen New Industries Biomedical (300832) has an Asset Resilience Ratio of 9.95% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 300832 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥953.21 Million

≈ $139.48 Million USD Cash + Short-term Investments

Total Assets

CN¥9.58 Billion

≈ $1.40 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Shenzhen New Industries Biomedical's Asset Resilience Ratio has changed over time. See 300832 equity to assets ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen New Industries Biomedical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300832 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥953.21 Million	9.95%
Total Liquid Assets	CN¥953.21 Million	9.95%

Asset Resilience Insights

Limited Liquidity: Shenzhen New Industries Biomedical maintains only 9.95% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Shenzhen New Industries Biomedical Industry Peers by Asset Resilience Ratio

Compare Shenzhen New Industries Biomedical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Medacta Group SA SW:MOVE	Medical Devices	0.86%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Jafron Biomedical Co Ltd SHE:300529	Medical Devices	39.15%
Sinocare Inc SHE:300298	Medical Devices	3.53%
Xiangyu Medical Co. Ltd. A SHG:688626	Medical Devices	1.53%
INKON Life Technology Co Ltd SHE:300143	Medical Devices	5.73%
HOB Biotech Group Corp Ltd SHG:688656	Medical Devices	2.62%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Annual Asset Resilience Ratio for Shenzhen New Industries Biomedical (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Shenzhen New Industries Biomedical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.92%	CN¥1.72 Billion ≈ $252.20 Million	CN¥9.62 Billion ≈ $1.41 Billion	-10.74pp
2023-12-31	28.65%	CN¥2.36 Billion ≈ $344.75 Million	CN¥8.22 Billion ≈ $1.20 Billion	-11.46pp
2022-12-31	40.11%	CN¥2.81 Billion ≈ $411.73 Million	CN¥7.01 Billion ≈ $1.03 Billion	-5.63pp
2021-12-31	45.74%	CN¥2.81 Billion ≈ $410.68 Million	CN¥6.14 Billion ≈ $897.82 Million	+2.39pp
2020-12-31	43.35%	CN¥2.30 Billion ≈ $336.58 Million	CN¥5.31 Billion ≈ $776.39 Million	--

pp = percentage points

About Shenzhen New Industries Biomedical

SHE:300832 China Medical Devices

Market Cap

$4.83 Billion

CN¥33.00 Billion CNY

Market Cap Rank

#3706 Global

#560 in China

Share Price

CN¥42.00

Change (1 day)

-1.64%

52-Week Range

CN¥42.00 - CN¥70.18

All Time High

CN¥98.01